Ex Ovo Chorioallantoic Membrane Assay as a Model of Bone Formation by Biomaterials
ACS Macro Letters · 2024
DOI: 10.1021/acsmacrolett.4c00343 ↗Kurz gefasst
Leserbrief in der Zeitschrift ACS Macro Letters, 2024. Verfasst von Nazanin Owji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Biomaterials Research Group, The RAFT Institute and The Griffin Institute, Northwick Park and Saint Mark's Hospitals, Harrow HA1 3UJ, Un…. Hauptthemen laut MEDLINE: Chorioallantoic Membrane, Osteogenesis, Biocompatible Materials, Tissue Engineering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, NextGenerationEU, Restoration of Appearance and Function Trust.
Abstract (Originalsprache)
Biomaterials play an increasingly critical role in bone tissue engineering. However, achieving effective clinical translation requires a careful choice of biomimetic materials and thorough assessment of their efficacy and safety. Existing in vitro and in vivo models have drawbacks including time and cost constraints, invasive procedures, and discordance between animal models and clinical outcomes. Therefore, there is a demand for an alternative model. We hypothesized that the chick embryo chorioallantoic membrane can serve as a bioreactor to evaluate the initial sign of bone formation on scaffolds. In parallel, we investigated the osteogenic potential of a previously fabricated fibrin-alginate-calcium phosphate biomaterial (FACaP). Blood vessels were observed to infiltrate the scaffolds with early signs of bone formation, confirmed via RUNX-2 and alpha smooth muscle actin markers. The scaffolds' chemical composition was evaluated by Fourier-transform infrared spectroscopy, and ion chromatography was used to assess calcium ion release. Finally, the topography was examined by atomic force microscopy. In conclusion, this system offers simple refinement for in vivo models in bone tissue engineering and highlights the great potential of FACaP as an angiogenic and osteogenic biomaterial for non-load-bearing applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Regenerative Biomaterials Research Group, The RAFT Institute and The Griffin Institute, Northwick Park and Saint Mark's Hospitals, Harrow HA1 3UJ, United Kingdom.
- Division of Biomaterials and Tissue Engineering, Eastman Dental Institute, University College London, London NW3 2QG, United Kingdom.
- Department of Biochemical Engineering, University College London, London WC1E 6BT, United Kingdom.
- Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates.
- Healthcare Engineering Innovation Center, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates.
- Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham B31 2AP, United Kingdom.
ORCID-Profile: Nazanin Owji, Prasad Sawadkar, Jonathan C Knowles, Elena García-Gareta
Förderung
- Ministerio de Ciencia, Innovaci?n y Universidades
- NextGenerationEU
- Restoration of Appearance and Function Trust
Zitieren
APA
Owji, N., Kohli, N., Frost, O. G., Sawadkar, P., Snow, M., Knowles, J. C., & García-Gareta, E. (2024). Ex Ovo Chorioallantoic Membrane Assay as a Model of Bone Formation by Biomaterials. ACS Macro Letters. https://doi.org/10.1021/acsmacrolett.4c00343
Vancouver
Owji N, Kohli N, Frost OG, Sawadkar P, Snow M, Knowles JC, et al. Ex Ovo Chorioallantoic Membrane Assay as a Model of Bone Formation by Biomaterials. ACS Macro Letters. 2024. doi:10.1021/acsmacrolett.4c00343
BibTeX
@article{Owji2024,
author = {Owji, Nazanin and Kohli, Nupur and Frost, Oliver G and Sawadkar, Prasad and Snow, Martyn and Knowles, Jonathan C and García-Gareta, Elena},
title = {Ex Ovo Chorioallantoic Membrane Assay as a Model of Bone Formation by Biomaterials},
journal = {ACS Macro Letters},
year = {2024},
doi = {10.1021/acsmacrolett.4c00343}
}
EUVIMED